These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15847367)

  • 1. Oral Sildenafil in the management of primary pulmonary hypertension.
    Malhotra S; Punia VP
    J Assoc Physicians India; 2004 Aug; 52():670-2. PubMed ID: 15847367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
    Kothari SS; Duggal B
    Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit.
    Jackson G; Chambers J
    Int J Clin Pract; 2002 Jun; 56(5):397-8. PubMed ID: 12137450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Derchi G; Forni GL; Formisano F; Cappellini MD; Galanello R; D'Ascola G; Bina P; Magnano C; Lamagna M
    Haematologica; 2005 Apr; 90(4):452-8. PubMed ID: 15820939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil in the management of primary pulmonary hypertension.
    Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U
    Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.
    Saygili A; Canter B; Iriz E; Kula S; Tunaoğlu FS; Olguntürk R; Ozdoğan ME
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):775-6. PubMed ID: 15650993
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
    Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
    Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
    Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
    Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
    Onen ZP; Akkoca Yildiz O; Eriş Gülbay B; Karabiyikoğlu G
    Tuberk Toraks; 2006; 54(2):177-81. PubMed ID: 16924576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.
    Sastry BK; Narasimhan C; Reddy NK; Anand B; Prakash GS; Raju PR; Kumar DN
    Indian Heart J; 2002; 54(4):410-4. PubMed ID: 12462670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension.
    Gough MS; White RJ
    Liver Transpl; 2009 Jan; 15(1):30-6. PubMed ID: 19109844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
    Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
    Sheth A; Park JE; Ong YE; Ho TB; Madden BP
    Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.